Interventional • Organizational benefit

VIVATEL

Organizational benefit

500

Patients enrolled in the program

3

Participating center(s) across the study

Study description

A French multicentric, retrospective database study assessing the benefit of Cureety remote monitoring for patients undergoing cancer treatment (during 6 months from first day of treatment).

Key results

Extraction of data: 541 patients eligible – analysis ongoing

Research collaboration

Discuss this study with our research team

Questions about methodology, results, or potential collaborations — our team is available to engage with researchers, clinicians and life sciences partners.